Posted by Michael Wonder on 29 Feb 2024
Regulator acts to close loophole enabling Australian pharmacists to make copycat Ozempic drug
29 February 2024 - The TGA will move to ban compounding pharmacists from making their own versions of injectable weight loss drugs due to concerns the compounded products may not be safe or effective.
The skyrocketing demand for drugs such as Ozempic and Mounjaro, which are approved for diabetes and widely used off-label for weight loss, has led to global supply problems and chronic shortages in Australia.
